Journal article
Excisional treatment comparison for in situ endocervical adenocarcinoma (EXCISE): A phase 2 pilot randomized controlled trial to compare histopathological margin status, specimen size and fragmentation after loop electrosurgical excision procedure and cold knife cone biopsy
PA Cohen, Y Leung, L Anderson, R van der Griend, P Chivers, S Bilic, S Bittinger, A Brand, MK Bulsara, J Codde, L Eva, L Farrell, D Harker, U Herbst, S Jeffares, D Loh, O McNally, GR Mohan, T Nicholson, A Powell Show all
Gynecologic Oncology | Published : 2020
Abstract
Objective: Adenocarcinoma in situ (AIS) of the cervix is a precursor to cervical adenocarcinoma. When AIS is detected by cervical screening an excision biopsy is mandatory to exclude invasion. We aimed to compare margins status, specimen size and fragmentation after loop electrosurgical excision procedure (LEEP) and ‘cold knife cone biopsy’ (CKC). Methods: The EXCISE Trial was an investigator-initiated, multicenter, open-label, parallel-group, phase 2, randomized study. Patients were enrolled at seven hospitals in Australia and New Zealand. We randomly assigned women aged ≥18 to ≤45 years with screen detected AIS to LEEP or CKC. Co-primary endpoints were margin status, specimen size and frag..
View full abstractGrants
Funding Acknowledgements
Australia New Zealand Gynaecological Oncology Group [#FNR2016/03].